Pharm
Ceftriaxone
search
Ceftriaxone
, Rocephin
See Also
Third Generation Broad-Spectrum Cephalosporin
Cephalosporin
Cefixime
Cefpodoxime
Cefdinir
Cefotaxime
Indications
Pneumonia
Pyelonephritis
Pelvic Inflammatory Disease
Sepsis
Meningitis
Skin and Soft Tissue Infection
s
Bone and Joint Infections
Intraabdominal infections
Gonorrhea
Lyme Disease
Chancroid
Typhoid Fever
Contraindications
Newborns
Kernicterus
risk in age <7-14 days
Some studies have shown safety in term infants with inconjugated
Hyperbilirubinemia
Amin (2023) J Pediatr 254:91-5 +PMID: 36336007 [PubMed]
Mechanism
See
Third Generation Broad-Spectrum Cephalosporin
Ceftriaxone has less
Staphylococcus
and Anaerobic activity than
Cefotaxime
Frequently used with
Metronidazole
(e.g. Intraabdominal infections,
Pelvic Inflammatory Disease
)
Dosing
Background
Dilute in
Lidocaine
1% for
Intramuscular Injection
(risk of
Methemoglobinemia
)
Child
Standard
Give 50-75 mg/kg/day (max 2 g/day) IV or IM divided every 12-24 hours
Meningitis
Give 100 mg/kg/day (max 4 g/day) IV divided every 12-24 hours (twice daily is preferred)
Otitis Media
Give 50 mg/kg IM single dose (max 1 g)
Adult
See
Gonorrhea
(and other specific indications listed above)
Standard
Give 1 to 2 grams IM or IV every 24 hours
In adults, 2 gram dose is preferred in >100 kg or critically ill patients
Maximum
Typical Maximum: 4 g/day divided every 12 hours
Lower Maximum: 2 g/day
Elderly
Hepatic dysfunction
Renal Dysfunction
Adverse Effects
Biliary disease exacerbation (e.g.
Biliary Colic
)
Ceftriaxone is excreted in bile and displaces
Bilirubin
from albumin binding
Risk of acalculous cholestasis
Safety
Pregnancy Category B
Safe in
Lactation
Drug Interactions
Prothrombin Time
or INR
Increased prothombin time
Intravenous Calcium
or
Calcium
Containing Solutions (e.g. LR,
Hartmann's Solution
, TPN)
Risk of Ceftriaxone and
Calcium
preciptation
Precipitation is also associated with lethal lung and
Renal Injury
in newborns
Resources
Ceftriaxone
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cd2d96f-83e5-4326-ae87-d0ede4ba493a
References
Hamilton (2020) Tarascon Pocket Pharmacopoeia
(2012) Presc Lett, Resource #280706, Comparison of
Cephalosporin
s
Type your search phrase here